Skip to main content
. Author manuscript; available in PMC: 2009 Jul 18.
Published in final edited form as: Immunity. 2008 Jul 18;29(1):21–32. doi: 10.1016/j.immuni.2008.05.013

Figure 6. HMGB1 function and Cys modification.

Figure 6

A. Cells expressing wild type p75 (p75wt) or mutated mitochondrial protein p75 (p75DA) were UV irradiated. Supernatants were collected for 0–6 hr or 6–24 hrs. HMGB1 was separated on a non-reducing SDS-PAGE gel and detected by western blotting with a polyclonal anti-HMGB1. B. Recombinant HMGB1 (rHMGB1), rHMGB1-C23S mutant (500ng/ml) rHMGB1-C45S (500ng/ml) mutant, or rHMGB1-C106S (500ng/ml) mutant was treated with DTT or H2O2 and added to TNP-DC that had been fed apoptotic spleen cells for 6 hrs. After overnight culture DC were harvested and injected i.v. into recipient mice that were immunized s.c. with TNBS 2 days later. Four days following immunization, mice were challenged with TNBS in the right footpad and PBS in the left footpad. Measurements (μm ± standard error) were taken 24 h later, and represent the difference between right footpad (antigen challenge) and left footpad (PBS challenge). Immune Control groups were injected with TNBS s.c. * denotes significantly different from Immune Control mice.